Author:
Cilley J,Rihn C,Monreal J,Gordon L I,Singhal S,Tallman M,Williams S,Winter J,Mehta J
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference16 articles.
1. Bortin MM, Gale RP, Kay HE, Rimm AA . Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. JAMA 1983; 249: 1166–1175.
2. Mehta J, Powles R, Treleaven J et al. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide–total body irradiation and cyclosporine. Bone Marrow Transplant 1996; 18: 741–746.
3. Körbling M, Huh YO, Durett A et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842–2848.
4. Mavroudis D, Read E, Cottler-Fox M et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996; 88: 3223–3229.
5. Powles R, Mehta J, Kulkarni S et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000; 355: 1231–1237.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献